Deals: Page 83
-
BMS and Allied Minds team up to turn academic research into a clinical reality
This venture will ultimately involve university researchers, the BMS team and experienced finance managers from Allied Minds.
By Nicole Gray • Aug. 5, 2014 -
Allergan files federal lawsuit against Valeant, Pershing Square
Allergan is accusing Valeant and Pershing Square of federal securities law violations, including insider trading and failing to disclose legally required information.
By Sy Mukherjee • Aug. 1, 2014 -
NICE gives Celgene's myeloma treatment the cold shoulder
The agency had previously approved use of Revlamid (lenalidomide) when Celgene had a patient access scheme in place.
By Nicole Gray • July 31, 2014 -
AZ buys rights to Almirall's respiratory portfolio in $2.1 billion deal
This deal signals AstraZeneca’s strength and independence.
By Nicole Gray • July 31, 2014 -
Can GSK overcome its Q2 blues by focusing on the future?
In the face of corruption allegations and diminished earnings forecasts, GSK is looking toward the horizon.
By Nicole Gray • July 29, 2014 -
Roche developing diagnostic test to support AZ's lung cancer candidate
Another example of how personalized medicine is improving cancer therapeutics.
By Nicole Gray • July 29, 2014 -
Boehringer and Zealand Pharma team up again to tackle obesity, diabetes
This is the second collaborative agreement between the two companies.
By Nicole Gray • July 29, 2014 -
Analysts on AbbVie's Shire deal: billions in tax savings
GlobalData analysts say moving business operations to Ireland will lower AbbVie’s taxes by 7%.
By Nicole Gray • July 29, 2014 -
Onco360 to distribute Gilead's Zydelig
PharMerica Corporation owns a substantial portion of Onco360.
By Nicole Gray • July 28, 2014 -
Reckitt Benckiser to spin off pharmaceutical business
RB Pharmaceuticals will become a stand-alone business, with the core company focusing on consumer health and hygiene.
By Nicole Gray • July 28, 2014 -
President Obama slams tax-inversion mergers: 'An unpatriotic tax loophole'
"We need to stop companies from renouncing their citizenship just to get out of paying their fair share of taxes," the president said Thursday.
By Sy Mukherjee • July 24, 2014 -
Lannett inks exclusive deal to distribute ACEON generic in the U.S.
Lannett will be the exclusive American distributor for a generic version of Symplmed Pharmaceuticals' hypertension drug ACEON.
By Nicole Gray • July 22, 2014 -
Major Allergan shareholder dumps stock in vote of no confidence
Capital Research and Management Co. is shedding almost all of its holdings in Botox-maker Allergan.
By Nicole Gray • July 22, 2014 -
AbbVie, Shire agree to $54.6 billion merger to slash corporate tax rate
This long-awaited cash-and-stock deal is a tax-inversion merger.
By Nicole Gray • July 18, 2014 -
Lilly, Immunocore partner to develop immunotherapy-based cancer treatments
Immunocore will receive up to $25 million for each candidate that is discovered and accepted by Lilly for clinical development.
By Nicole Gray • July 17, 2014 -
Dicerna Pharmaceuticals moving to Cambridge, MA
The company, which had the largest biotech IPO in MA so far this year, is doubling its footprint and moving into a former Pfizer space.
By Nicole Gray • July 17, 2014 -
Pfizer brings InnoPharma into the fold
The deal is worth up to $360 million and brings a strong portfolio of approved drugs and an even stronger pipeline.
By Nicole Gray • July 17, 2014 -
Oncology CROs merging to offer broader range of services
The goal of the merger between Chiltern and Ockham is to become the “premier specialized mid-tier CRO" for oncology services.
By Nicole Gray • July 16, 2014 -
Valeant moves forward with premerger notification to FTC, Allergan holds its own
The company is filing under the FTC’s Hart-Scott-Rodino Antitrust Improvement Act of 1976.
By Nicole Gray • July 15, 2014 -
AbbVie increases offer price for Shire
The deal is now valued at $53 billion.
By Nicole Gray • July 15, 2014 -
Abbott selling part of generics portfolio to Mylan
The transaction, which is valued at $5.3 billion, will close in Q1 2015
By Nicole Gray • July 15, 2014 -
HD Biosciences, Marshall U. launch Chinese drug venture
The partners will share costs, risks of development.
By Nicole Gray • July 14, 2014 -
Bayer, Oxford partner on gynecology research
Endometriosis and uterine fibroids affect millions of women worldwide.
By Nicole Gray • July 14, 2014 -
Pfizer, CliniWorks creating health management platform
It is being developed to deliver real-time healthcare that is both more efficient and more effective.
By Nicole Gray • July 11, 2014 -
Allergan making moves to be leaner
As Valeant’s hostile takeover efforts continue, Allergan starts cutting costs.
By Nicole Gray • July 10, 2014
Previous
